Villers-lès-Nancy, June 30, 2014 - 18h30 (CET)
PRESS RELEASE
For immediate release
RESULTS OF THE VOTE OF THE RESOLUTIONS
SUBMITTED TO THE ANNUAL ORDINARY AND EXTRAORDINARY GENERAL MEETING
HELD ON JUNE 27, 2014
Number of shares making up the share capital: 3.034.825
Number of voting shares owned by shareholders present or represented or having voted by mail: 2.296.254
The Annual Ordinary and Extraordinary General Meeting was held on June 27, 2014 and approved the financial statements and the consolidated financial statements for the fiscal year ended December 31, 2013. Hereafter the result of the votes of the resolutions submitted by the company's Board of Directors:
| Resolutions Annual Ordinary General Meeting | Results of the votes |
| Resolution adopted unanimously. |
| Resolution adopted by : - 2.278.378 votes in favor - 17.876 votes against. |
| Resolution adopted unanimously. |
| Resolution adopted unanimously. |
| Resolution adopted by : - 2.164.097 votes in favor - 132.157 votes against. |
| Resolution adopted by : - 2.072.857 votes in favor - 132.157 votes against. |
| Resolution adopted by : - 2.164.097 votes in favor, - 132.157 votes against. |
| Resolution adopted unanimously. |
| Resolution adopted by : - 2.146.221 votes in favor - 150.033 votes against. |
| Resolutions Annual Ordinary General Meeting (suite) | Results of the votes |
| Resolution adopted unanimously. |
| Resolution adopted by : - 2.279.006 votes in favor - 17.248 votes against. |
| Resolution adopted by : - 2.277.007 votes in favor - 19.247 votes against. |
| Resolution adopted by: - 2.207.444 votes in favor - 88.810 votes against. |
| Resolution adopted by : - 2.278.631 votes in favor - 17.623 votes against. |
| Resolution adopted by : - 2.207.444 votes in favor - 88.810 votes against. |
| Resolution adopted unanimously. |
| Resolution adopted by : - 2.284.878 votes in favor - 11.376 votes against. |
| Resolutions Extraordinary General Meeting | Results of the votes |
| Resolution adopted by : - 2.145.617 votes in favor - 150.637 votes against. |
| Resolution adopted unanimously. |
DIVIDENDS
PHARMAGEST INTERACTIVE, at its Annual Ordinary General Meeting of June 27, 2014, decided the payment of a dividend amounting to 2.50 Euros per share. The dividend will be payable on July 4, 2014.
The ex-dividend date will be July 1, 2014.
About the PHARMAGEST Group:
The PHARMAGEST Group is the French leader in computer systems for pharmacies, with a 43.5 % share of the market, 9,800 clients and more than 750 employees. Since September 2007, the PHARMAGEST Group has also been present in Northern Europe with a 12 % market share in Belgium and Luxembourg through its subsidiary SABCO.
As a privileged partner to pharmacists for almost 30 years now, the PHARMAGEST Group designs innovative computer solutions for pharmacies and is developing a high potential E-Business E-Media activity intended for laboratories.
The PHARMAGEST Group is also developing previously unpublished software solutions for Retirement Homes, (Care Homes and day centres for the elderly), through its subsidiary MALTA INFORMATIQUE.
The first Logiciel de Gestion à Portail Intégré (Integrated Portal Management Software - LGPI Global Services®), creator of value for the patient, pharmacist and laboratory, dynamises sales, optimises purchases and enriches advice to the patient. It is also the first permanent impact medium for pharmacies, supplying laboratories with direct communication towards the pharmacist and his patients.
At the heart of the digital revolution that is gradually establishing itself in the daily life of health professionals and patients alike, at the beginning of 2012, the PHARMAGEST Group created an e-Health business, bringing together the subsidiaries DIATELIC (telemedicine and e-health solutions) and DOMEDIC EUROPE (intelligent pill dispenser DO-Pill SecuRTM ).
Listed on the NYSE Euronext Paris(TM) - Compartment B
Indices CAC ® SMALL90 and CAC ® All-Tradable by inclusion
ISIN: FR 0000077687 - Reuters: PHA.PA - Bloomberg: - PMGI FP
Find out the latest news from the group at www.pharmagest.com
Contacts :
Analysts and Investor Relations:
Administrative and Financial Director: Jean-Yves SAMSON
Tel. 03 83 15 90 67 - jean-yves.samson@pharmagest.com
Press Relations:
FIN'EXTENSO - Isabelle APRILE
Tel. 01 39 97 61 22 - i.aprile@finextenso.fr
